Physician profile
Brian E Diskin
NPI 1306257456
$4,366.92
in general payments reported to CMS, 2019-2025
9 companies · $4,330 in 2025
The $4,330 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $37.14 · 2025: $4,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $897 · Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $896.83 |
| Food and Beverage | $470.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,154.38 | 2025 | |
| Histosonics, INC. | $896.83 | 2025 | |
| Hologic Sales and Service, LLC | $110.20 | 2025 | Magtrace |
| Endomagnetics Ltd | $53.20 | 2025 | Magseed, Magtrace, Sentimag |
| Ethicon US, LLC | $37.14 | 2024 | Echelon Endopath |
| Tersera Therapeutics LLC | $35.93 | 2025 | Zoladex |
| Novartis Pharmaceuticals Corporation | $33.62 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $29.46 | 2025 | |
| Daiichi Sankyo INC. | $16.16 | 2025 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Diskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.